Blood Markers of Early Pancreas Cancer

University of Nebraska
Recruiting ID
For more information, see NCT03568630
Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease.

The investigators propose a longitudinal study of subjects at higher than average risk of PDAC in order to generate clinical data and bank serial blood specimens.
Hemoglobin A1c, Mixed Meal Tolerance Test, Other exploratory blood biomarkers
Diabetes Mellitus, Type 2, PreDiabetes, Pancreas Cyst, Chronic Pancreatitis, Genetic Predisposition to Disease, Inherited Disease
Kelsey A. Klute, MD, Suzanne M Wessling, RN, BSN

See list of participating sites